The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study
Abstract
Cerivastatin is used in the treatment of hypercholesterolemia to inhibit 3-hydroxy 3-methylglutaryl coenzyme A reductase and thus prevent the synthesis of cholesterol precursors, such as farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), responsible, respectively, for translocation of Ras and Rho to the cell membrane, a step required for their cell signaling, leading to cell proliferation and migration. Recently, it has been suggested that non lipid-related effects of statins could play a beneficial role in cancer therapy. In this study, we have investigated the mechanisms by which statins inhibit cancer and the types of cancers which could benefit from this therapy. In MDA-MB-231 cells, an aggressive breast cancer cell line with spontaneous activation of Ras and NFkappaB and overexpression of RhoA, cerivastatin induced inhibition of both cell proliferation and invasion through Matrigel. This anti-proliferative effect was related to G(1)/S arrest due to an increase in p21(Waf1/Cip1). The anti-invasive effect was observed from 18 h and could be explained by RhoA delocalization from the cell membrane, resulting in disorganization of the actin fibers and disappearance of focal adhesion sites. The importance of RhoA inactivation in both these inhibitory effects was proved by their reversion by GGPP but not by FPP. Moreover, cerivastatin was also shown to induce inactivation of NFkappaB, in a RhoA inhibition-dependent manner, resulting in a decrease in urokinase and metalloproteinase-9 expression, two proteases involved in cell migration. The participation of Ras inactivation is considered a subsidiary mechanism for the effects of cerivastatin, as they were not rescued by FPP. Prolonged treatment of MDA-MB-231 cells with high doses of cerivastatin induced a loss of cell attachment. Interestingly, the effect of cerivastatin was considerably lower on poorly invasive MCF-7 cells. In conclusion, our results suggest that cerivastatin inhibits cell signaling pathways involved in the invasiveness and metastatic properties of highly invasive cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,096
Signal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
An Essential Role for Rho, Rac, and Cdc42 GTPases in Cell Cycle Progression Through G 1
Olson, M. F., Ashworth, A., & Hall, A. (1995) · Science · doi:10.1126/science.7652575 · Cited by 1,146
Increasing complexity of Ras signaling
Campbell, S. L., Khosravi-Far, R., Rossman, K. L., Clark, G. J., & Der, C. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202174 · Cited by 1,079
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 819
Microinjection of recombinant p21rho induces rapid changes in cell morphology.
Paterson, H. F., Self, A. J., Garrett, M. D., Just, I., Aktories, K., & Hall, A. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.3.1001 · Cited by 718
Harris, J. R., Lippman, M. E., Veronesi, U., & Willett, W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207303270505 · Cited by 701
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation
Khosravi-Far, R., Solski, P. A., Clark, G. J., Kinch, M. S., & Der, C. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6443 · Cited by 683
Rho GTPases are over-expressed in human tumors
Fritz, G., Just, I., & Kaina, B. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990531)81:5<682::aid-ijc2>3.0.co;2-b · Cited by 659
An essential part for Rho–associated kinase in the transcellular invasion of tumor cells
Itoh, K., Yoshioka, K., Akedo, H., Uehata, M., Ishizaki, T., & Narumiya, S. (1999) · Nature Medicine · doi:10.1038/5587 · Cited by 600
Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins
Perona, R., Montaner, S., Saniger, L., Sánchez-Pérez, I., Bravo, R., & Lacal, J. C. (1997) · Genes & Development · doi:10.1101/gad.11.4.463 · Cited by 519
Bond, M., Fabunmi, R. P., Baker, A. H., & Newby, A. C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01034-5 · Cited by 512
Herz, J., Clouthier, D. E., & Hammer, R. E. (1992) · Cell · doi:10.1016/0092-8674(92)90511-a · Cited by 497
Schmitt, M., Harbeck, N., Thomssen, C., et al. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657541 · Cited by 386
Non-lipid-related effects of statins
Bellosta, S., Fed, N., Bernini, F., Paoletti, R., & Corsini, A. (2000) · Annals of Medicine · doi:10.3109/07853890008998823 · Cited by 333
Garcia, J. A., Wu, F. K., Mitsuyasu, R., & Gaynor, R. B. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02711.x · Cited by 293
The 70 kDa S6 Kinase Complexes with and Is Activated by the Rho Family G Proteins Cdc42 and Rac1
Chou, M. M., & Blenis, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81257-x · Cited by 292
Pedersen, T. R., Wilhelmsen, L., Færgeman, O., Strandberg, T. E., Thorgeirsson, G., Troedsson, L., Kristianson, J., Berg, K., Cook, T. J., Haghfelt, T., et al. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00910-3 · Cited by 274
Regulation of the Tissue Factor Gene
Mackman, N. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657623 · Cited by 272
Critical role of Rho in cell transformation by oncogenic Ras.
Prendergast, G. C., Khosravi‐Far, R., Solski, P. A., Kurzawa, H., Lebowitz, P. F., & Der, C. J. (1995) · PubMed · Cited by 253
Vindeløv, L. L., & Christensen, I. J. (1990) · Cytometry · doi:10.1002/cyto.990110702 · Cited by 248
Rho-Kinase Inhibitor Retards Migration and in Vivo Dissemination of Human Prostate Cancer Cells
Somlyo, A. V., Bradshaw, D., Ramos, S., Murphy, C., Myers, C. E., & Somlyo, A. P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2343 · Cited by 241
Involvement of rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in cell motility.
Takaishi, K., Kikuchi, A., Kuroda, S., Kotani, K., Sasaki, T., & Takai, Y. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.72 · Cited by 198
Finco, T. S., & Baldwin, A. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46756-1 · Cited by 185
Blasi, F. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615846 · Cited by 172
Hansen, S. K., Nerlov, C., Zabel, U., Verde, P., Johnsen, M., Baeuerle, P. A., & Blasi, F. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05043.x · Cited by 168
Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells.
Yoshioka, K., Nakamori, S., & Itoh, K. (1999) · PubMed · Cited by 162
Small GTP-binding Protein Rho Stimulates the Actomyosin System, Leading to Invasion of Tumor Cells
Yoshioka, K., Matsumura, F., Akedo, H., & Itoh, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5146 · Cited by 154
Tissue factor in cancer angiogenesis and metastasis
Ruf, W., & Mueller, B. M. (1996) · Current Opinion in Hematology · doi:10.1097/00062752-199603050-00008 · Cited by 136
Kozma, S. C., Bogaard, M. E., Buser, K., Saurer, S., Bos, J. L., Groner, B., & Hynes, N. E. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.15.5963 · Cited by 127
Domain Organization of IκBα and Sites of Interaction with NF-κB p65
Jaffray, E., Wood, K. M., & Hay, R. T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.2166 · Cited by 121
Allal, B., Favre, G., Couderc, B. C., Salicio, S., Doisneau-Sixou, S. F., Hamilton, A. D., Sebti, S. M., Lajoie‐Mazenc, I., & Pradines, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005264200 · Cited by 119
Tumorigenic activity of rho genes from Aplysia californica.
Perona, R., Esteve, P., Jiménez, B., Ballestero, R. P., y Cajal, S. R., & Lacal, J. C. (1993) · PubMed · Cited by 106
Localization of RhoA GTPase to Endothelial Caveolae-Enriched Membrane Domains
Gingras, D. J., Gauthier, F., Lamy, S., Desrosiers, R. R., & Béliveau, R. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8885 · Cited by 106
The Small GTP-Binding Protein Rho Potentiates AP-1 Transcription in T Cells
Chang, J., Pratt, J. C., Sawasdikosol, S., Kapeller, R., & Burakoff, S. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.4986 · Cited by 89
Gray-Bablin, J., Rao, S., & Keyomarsi, K. (1997) · PubMed · Cited by 87
Lovastatin Inhibits Tumor Growth and Metastasis Development of a Rat Fibrosarcoma
Matar, P., Rozados, V. R., Roggero, E., et al. (1998) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1998.13.387 · Cited by 48
Cited by
Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021) · Cancers · doi:10.3390/cancers13174287 · Cited by 1,960
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030
Demierre, M.-F., Higgins, P. D. R., Gruber, S. B., Hawk, E., & Lippman, S. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1751 · Cited by 819
Statin Use and Reduced Cancer-Related Mortality
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1214827 · Cited by 720
Mevalonate pathway: A review of clinical and therapeutical implications
Buhaescu, I., & Izzedine, H. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.03.016 · Cited by 620
Metadata
- Authors
- Denoyelle, C.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-08-01
- Volume
- 22
- Issue
- 8
- Pages
- 1139-1148
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2141570734
- Cited by
- 310
- References
- 41
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.